IRIS
D'ANGELO, ANGELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.025
AS - Asia 4.765
EU - Europa 4.310
SA - Sud America 705
AF - Africa 86
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 15.900
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.912
CN - Cina 2.816
IE - Irlanda 1.071
SG - Singapore 959
DE - Germania 642
UA - Ucraina 639
BR - Brasile 592
FI - Finlandia 578
HK - Hong Kong 486
RU - Federazione Russa 476
SE - Svezia 240
IT - Italia 215
GB - Regno Unito 214
VN - Vietnam 194
CA - Canada 73
FR - Francia 70
IN - India 70
AR - Argentina 40
BD - Bangladesh 40
ZA - Sudafrica 34
JP - Giappone 32
TR - Turchia 30
BE - Belgio 29
ID - Indonesia 27
MX - Messico 25
EC - Ecuador 23
NL - Olanda 23
ES - Italia 22
IQ - Iraq 22
PL - Polonia 21
PE - Perù 15
EG - Egitto 11
UZ - Uzbekistan 11
CZ - Repubblica Ceca 10
JO - Giordania 10
PK - Pakistan 10
PY - Paraguay 10
VE - Venezuela 10
AT - Austria 8
LT - Lituania 8
MU - Mauritius 8
IL - Israele 7
MA - Marocco 7
CO - Colombia 6
KZ - Kazakistan 6
RO - Romania 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
BO - Bolivia 5
MK - Macedonia 5
SA - Arabia Saudita 5
TN - Tunisia 5
CR - Costa Rica 4
NZ - Nuova Zelanda 4
PH - Filippine 4
PT - Portogallo 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
CH - Svizzera 3
DZ - Algeria 3
ET - Etiopia 3
GE - Georgia 3
HN - Honduras 3
NO - Norvegia 3
OM - Oman 3
PA - Panama 3
SN - Senegal 3
AL - Albania 2
AU - Australia 2
BG - Bulgaria 2
CL - Cile 2
DJ - Gibuti 2
EE - Estonia 2
GR - Grecia 2
HU - Ungheria 2
IS - Islanda 2
JM - Giamaica 2
KE - Kenya 2
KG - Kirghizistan 2
KH - Cambogia 2
KR - Corea 2
LB - Libano 2
LV - Lettonia 2
MG - Madagascar 2
NC - Nuova Caledonia 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CD - Congo 1
CG - Congo 1
CU - Cuba 1
DO - Repubblica Dominicana 1
EU - Europa 1
IM - Isola di Man 1
IR - Iran 1
LK - Sri Lanka 1
LU - Lussemburgo 1
Totale 15.891
Salva come PNG Salva come JPEG
Città #
Dublin 1.071
Chandler 894
Jacksonville 848
Nanjing 655
Dallas 536
Hong Kong 486
Singapore 425
Beijing 407
Ashburn 406
Boardman 327
Nanchang 287
Munich 204
Shenyang 200
Princeton 194
Lawrence 190
Medford 186
Helsinki 185
Hebei 180
Wilmington 173
Changsha 171
Jiaxing 162
Los Angeles 156
Hangzhou 110
Tianjin 102
Ann Arbor 90
Redondo Beach 88
Moscow 86
Buffalo 77
Shanghai 77
Ho Chi Minh City 69
São Paulo 62
New York 58
Woodbridge 53
Cambridge 51
Turku 50
Milan 41
Seattle 40
Toronto 39
Hanoi 38
Piscataway 31
Pavia 28
Santa Clara 28
Brussels 27
Tokyo 27
Fairfield 26
Johannesburg 25
Pune 25
Norwalk 24
Des Moines 22
Jinan 22
Montreal 22
Rio de Janeiro 22
Brooklyn 21
Kunming 21
Orem 21
Stockholm 20
Guangzhou 19
San Francisco 19
The Dalles 18
Verona 17
Chennai 16
London 16
Belo Horizonte 15
Chicago 15
Ankara 14
Boston 14
Falkenstein 14
Atlanta 13
Denver 13
Frankfurt am Main 13
Charlotte 12
Taizhou 12
Warsaw 12
Zhengzhou 12
Campinas 11
Houston 11
Ningbo 11
Orange 11
Phoenix 11
Quito 11
Tashkent 11
Washington 11
Poplar 10
Amman 9
Baghdad 9
Curitiba 9
Dhaka 9
Salvador 9
Brno 8
Fuzhou 8
Haiphong 8
Trujillo 8
West Jordan 8
Berlin 7
Brasília 7
Bắc Ninh 7
Eindhoven 7
Jakarta 7
Porto Alegre 7
Columbus 6
Totale 10.381
Salva come PNG Salva come JPEG
Nome #
Barnidipine or Lercanidipine on Echocardiographic Parameters in Hypertensive, Type 2 Diabetics with Left Ventricular Hypertrophy: A Randomized Clinical Trial 231
Metabolic effect of repaglinide or acarbose when added to a double oral antidiabetic treatment with sulphonylureas and metformin: a double-blind, cross-over, clinical trial 166
A possible way to improve the glycemic control and the beta cell function during three years: the triple therapy. 141
Plasma eotaxin concentrations are associated with angiographic severity of coronary artery disease 134
Significance of apolipoprotein(a) phenotypes in acute coronary syndromes: relation with clinical presentation. 130
Absence of Kir6.1/KCNJ8 mutations in Italian patients with abnormal coronary vasomotion 126
Relationship between apolipoprotein(a) size polimorphism and coronary heart disease in overweight subjects 124
RAGE : a central player in nondiabetic vascular disease 122
The Apolipoprotein(a) Component of Lipoprotein(a) Mediates Binding to Laminin: Contribution to Selective Retention of Lipoprotein(a) in Atherosclerotic Lesions 120
Effect of Diazepam on 24-Hour Blood Pressure and Heart Rate in Healthy Young Volunteers 119
Relationship between plasma levels of soluble receptor for advanced glycation end products (sRAGE) and coronary artery disease 118
Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension 112
A randomized, double-blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients 112
The apolipoprotein(a) component of lipoprotein(a) mediates binding to laminin:contribution to selective retention of lipoprotein(a) in atherosclerotic lesions. 110
Different actions of losartan and ramipril on adipose tissue Activity and vascular remodeling biomarkers in hypertensive patients 110
Confronto tra nateglinide più metformina rispetto a glibenclamide più metformina sul metabolismo glucidico nei pazienti diabetici di tipo 2: studio ad 1 anno 110
Abscisic Acid Treatment in Patients with Prediabetes. 110
Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men 107
Association of plasma eotaxin levels with the presence and extent of angiographic coronary artery disease 106
Effects of combination of sibutramine and L-carnitine compared with sibutramine monotherapy on inflammatory parameters in diabetic patients 106
ATPases of synaptic plasma membranes and vesicles from rat cerebral cortex during aging and hypoxia 105
Acarbose on insulin resistance after an oral fat load: a double-blind, placebo controlled study 105
Differential effect of candesartan and olmesartan on adipose tissue activity biomarkers in type 2 diabetic hypertensive patients 105
Azione della moxonidina sul metabolismo glucidico e lipidico negli ipertesi con sindrome metabolica 105
Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus 105
The regulatory chemokine eotaxin-3 is a novel predictor of cardiovascular outcome in patients with coronary artery disease 104
Galectin-3 plasma levels andcoronary artery disease: a new possible biomarker of acute coronary syndrome. 104
High levels of soluble receptor for advanced glycation end products may be a marker of extreme longevity in humans 100
Comparison between orlistat plus l-carnitine and orlistat alone on inflammation parameters in obese diabetic patients 100
Acarbose compared to placebo on insulin resistance biomarkers in a double-blind, placebo-controlled trial 100
A study about the relevance of adding acetylsalicylic acid in primary prevention in subjects with type 2 diabetes mellitus: effects on some new emerging biomarkers of cardiovascular risk 100
Acarbose actions on insulin resistance and inflammatory parameters during an oral fat load 100
Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in combined dyslipidemia 99
CORRELAZIONE TRA I LIVELLI PLASMATICI DI NEUROTROFINE, SINTOMATOLOGIA DEPRESSIVA E ATEROSCLEROSI CORONARICA 99
Biomarcatori infiammatori e neuro-ormonali nella fibrillazione atriale persistente; ruolo prognostico della concentrazione plasmatica di apelina 98
Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus. 98
A clinical trial about a food supplement containing α-lipoic acid on oxidative stress markers in type 2 diabetic patients 97
Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial 97
Differenti effetti di candesartan e olmesartan sui parametri di attività del tessuto adiposo in pazienti diabetici di tipo 2 ipertesi 96
Effetti metabolici di telmisartan e irbesartan nei pazienti diabetici di tipo 2 con sindrome metabolica trattati con rosiglitazone 96
Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study 96
Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome 95
Effetti di pioglitazone e rosiglitazone nei pazienti con diabete di tipo 2 e sindrome metabolica trattati con metformina 95
Effect of Evening Bromazepam Administration on Blood Pressure and Heart Rate in Mild Hypertensive Patients 94
Twenty-four-hour blood pressure profile, orthostatic hypotension, and cardiac dysautonomia in elderly type 2 diabetic hypertensive patients 93
Elevated plasma levels of lipoprotein(a) in psychiatric patients: a possible contribution to increased vascular risk 92
Correlazione tra livelli plasmatici di galactina e aterosclerosi coronarica: nuovo marcatore di instabilità clinica? 92
Effetti di un anno di trattamento con vildagliptin associato a pioglitazone o glimepiride in pazienti diabetici scarsamente controllati 92
Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients 91
Effetti di un anno di trattamento con orlistat+L-carnitina paragonato a orlistat o placebo sui parametri di insulino-resistenza nei pazienti diabetici 91
Berberis aristata combined with Silybum marianum on lipid profile in patients not tolerating statins at high doses. 91
Low plasma apelin levels predict arrhythmia recurrence in patients with persistent atrial fibrillation 91
Lipoprotein (a) Particles Characterization by Dynamic Light Scattering 91
Effect of flunitrazepam as an oral hypnotic on 24-hour blood pressure in healthy volunteers. 91
Apolipoprotein(a) phenotypes are reliable biomarkers for familial aggregation of coronary heart disease 91
Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone 90
Metalloproteasi-2, metalloproteasi-9 ed inibitore tissutale delle metalloproteasi-1 in pazienti ipertesi 90
Action of L-acetylcarnitine on different cerebral mitochondrial populations from cerebral cortex 90
Barnidipine compared to lercanidipine in addition to losartan on endothelial damage and oxidative stress parameters in patients with hypertension and type 2 diabetes mellitus 89
Effects of a combination of Berberis aristata, Silybum marianum and monacolin on lipid profile in subjects at low cardiovascular risk; a double-blind, randomized, placebo-controlled trial 89
Benzodiazepins and cardiovascular risk: recent acquisitions and revision of literature. 89
Variation of inflammatory parameters after sibutramine treatment compared to placebo in type 2 diabetic patients 88
Relationship between sRAGE and eotaxin-3 with CRP in hypertensive patients at high cardiovascular risk. 88
Thiazolidinedione effects on blood pressure in diabetic patients with metabolic syndrome treated with glimepiride 87
Telmisartan ed irbesartan nei diabetii di tipo 2 trattati con rosiglitazone: effetti sull'insulino-resistenza, la leptine e il TNF-alfa 87
Microalbuminuria and sRAGE in High-Risk Hypertensive Patients Treated with Nifedipine/Telmisartan Combination Treatment: A Substudy of TALENT 87
Effetti metabolici di telmisartan e irbesartan nei apzienti diabetici di tipo 2 con sindrome metabolica trattati con rosiglitazone 86
Effects of berberine on lipid profile in subjects with low cardiovascular risk 86
The efficacy and safety of pioglitazone or rosiglitazone added onto metformin in type 2 diabetes patients with metabolic syndrome 86
Le metalloprotesi -2 e -9 e i loro inibitori tissutali -1 e -2 nei soggetti sani e nei soggetti con diabete di tipo 2 86
Ambulatory 24-h ECG monitoring and cardiovascular autonomic assessment for the screening of silent myocardial ischemia in elderly type 2 diabetic hypertensive patients 86
Effetti dell'associazione tra pioglitazone e sibutramina sul metabolismo glucidico e lipidico nei soggetti obesi diabetici di tipo 2 85
Circulating levels of soluble receptor for advanced glycation end products in neurodegenerative and vascular dementia 84
Candesartan effect on inflammation in hypertension 84
Effect of pioglitazone and acarbose on endothelial inflammation biomarkers during oral glucose tolerance test in diabetic patients treated with sulphonylureas and metformin 83
Different aspects of sartan + calcium antagonist association compared to the single therapy on inflammation and metabolic parameters in hypertensive patients 83
Prevalence and associations of erectile dysfunction in a sample of italian males with type 2 diabetes. 82
Markers of eosinophilic inflammation and risk prediction in patients with coronary artery disease 82
MMP-2, -9 and TIMP-1 in patients with hypertension before and after doxazosin therapy 82
Effetti metabolici di telmisartan e di irbesartan in pazienti diabetici di tipo 2 con sindrome metabolica trattati con rosiglitazone: un trial clinico randomizzato a doppio cieco 81
The efficacy and safety of pioglitazone or rosiglitazone added onto metformin on diabetic dyslipidemia 81
Berberis aristata/Silybum marianum fixed combination (Berberol®) effects on lipid profile in dyslipidemic patients intolerant to statins at high dosages: A randomized, placebo-controlled, clinical trial. 81
Effect of in vivo administration of naloxone on ATP-ase's enzyme systems of synaptic plasma membranes from rat cerebral cortex 81
Efficacia e sicurezza di pioglitazone o rosiglitazone in combinazione con metformina in pazienti con diabete di tipo 2 e sindrome metabolica 79
Diazepam as an oral hypnotic increases nocturnal blood pressure in the elderly. 79
Orlistat and L-carnitine compared to orlistat alone on insulin resistance in obese diabetic patients 78
Bicarbonate dialysis compared to hemodiafiltration on glycemic excursions in patients with end-stage renal disease with and without type 2 diabetes mellitus 78
Effects of oral administration of alprazolam and lorazepam as hypnotics on cardiovascular parameters in hypertensive patients. 78
Prevalence of erectile dysfunction in males affected by type 2 diabetes and the impact of hyperinsulinemia 77
Continuous glucose monitoring system in free-living healthy subjects: results from a pilot study 76
Metformin-pioglitazone and metformin-rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome 76
Matrix metalloproteinases and tissue inhibitor metalloproteinases in hypertensive patients 76
Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone 76
Olmesartan/amlodipine combination vs olmesartan or amlodipine monotherapies on blood pressure and insulin resistance in a sample of hypertensive patients 76
Comparison of the effects of barnidipine+losartan compared with telmisartan+hydrochlorothiazide on several parameters of insulin sensitivity in patients with hypertension and type 2 diabetes mellitus 76
Effects on oral fat load of a nutraceutical combination of fermented red rice, sterol esters and stanols, curcumin, and olive polyphenols: A randomized, placebo controlled trial 76
A role for quercetin in coronavirus disease 2019 (COVID-19) 75
La terapia con rosiglitazone migliora i parametri di insulino-resisitenza nei pazienti diabetici in sovrappeso ed obesi intolleranti alla metformina 75
Effect of naproxen and acetaminophen on blood pressure lowering by ramipril, valsartan and aliskiren in hypertensive patients 75
Ascophyllum nodosum and Fucus vesiculosus on glycemic status and on endothelial damage markers in dysglicemic patients 75
Totale 9.607
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.503
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.503
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021784 0 0 0 0 0 160 9 187 43 186 157 42
2021/2022740 12 4 30 5 6 10 5 46 44 15 119 444
2022/20232.855 286 200 20 189 282 283 2 163 1.253 35 89 53
2023/2024964 110 179 27 57 87 223 3 100 9 39 61 69
2024/20252.899 28 235 88 73 57 145 234 240 688 87 315 709
2025/20263.438 551 420 831 714 730 192 0 0 0 0 0 0
Totale 16.131